USH2A and retinitis pigmentosa: Van Wijk and colleagues showed that a protein domain-based skipping of (multiple) exons, based on a powerful combination of 3D bioinformatic modeling with in vitro and in vivo models, is a highly promising treatment paradigm for retinitis pigmentosa caused by pathogenic variants in the USH2A gene.